Search

Golub, T. R. 2003. “Mining the Genome for Combination Therapies”. Nat Med 9: 510-1.

Golub, T. R. 2007. “Genomics: Global Views of Leukaemia”. Nature 446: 739-40.

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1996. “Involvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 211: 279-88.

Halmos, B., D. S. Basseres, S. Monti, F. D’Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen. 2004. “A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3 Beta As a Novel Tumor Suppressor in Lung Cancer”. Cancer Res 64: 4137-47.

Hoshida, Y., and T. R. Golub. 2009. “Prolonged Therapy for Hepatitis C With Low-Dose Peginterferon”. N Engl J Med 360: 1152; author reply 1152-3.

Stathias, V., A. M. Jermakowicz, M. E. Maloof, M. Forlin, W. Walters, R. K. Suter, M. A. Durante, et al. 2018. “Drug and Disease Signature Integration Identifies Synergistic Combinations in Glioblastoma”. Nat Commun 9: 5315.

Stegmaier, K., S. Takeuchi, T. R. Golub, S. K. Bohlander, C. R. Bartram, and H. P. Koeffler. 1996. “Mutational Analysis of the Candidate Tumor Suppressor Genes TEL and KIP1 in Childhood Acute Lymphoblastic Leukemia”. Cancer Res 56: 1413-7.

Subramanian, A., R. Narayan, S. M. Corsello, D. D. Peck, T. E. Natoli, X. Lu, J. Gould, et al. 2017. “A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles”. Cell 171: 1437-1452 e17.

Tirosh, I., A. S. Venteicher, C. Hebert, L. E. Escalante, A. P. Patel, K. Yizhak, J. M. Fisher, et al. 2016. “Single-Cell RNA-Seq Supports a Developmental Hierarchy in Human Oligodendroglioma”. Nature 539: 309-13.

Viswanathan, S. R., J. T. Powers, W. Einhorn, Y. Hoshida, T. L. Ng, S. Toffanin, M. O’Sullivan, et al. 2009. “Lin28 Promotes Transformation and Is Associated With Advanced Human Malignancies”. Nat Genet 41: 843-8.